Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Current status of flavivirus vaccines
Alan D.T. Barrett
Pathology
Research output
:
Contribution to journal
›
Article
›
peer-review
61
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Current status of flavivirus vaccines'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Flavivirus
100%
Yellow Fever
100%
Flavivirus Vaccine
100%
Live Attenuated
66%
17D Vaccine
66%
Japanese Encephalitis
66%
Immunogen
33%
Recombinant
33%
Virus Vaccine
33%
Clinical Trials
33%
DNA Vaccine
33%
Reverse Genetics
33%
Live Attenuated Vaccine
33%
Dengue
33%
Japanese Encephalitis Virus
33%
Dengue Virus
33%
Envelope Protein Gene
33%
SA14-14-2
33%
Chimeric Virus
33%
ChimeraX
33%
Experimental Vaccines
33%
Dengue Vaccine
33%
Tetravalent
33%
Tick-borne Encephalitis Virus
33%
Inactivated Vaccine
33%
Premembrane Protein
33%
Pharmacology, Toxicology and Pharmaceutical Science
Flavivirus
100%
Yellow Fever
75%
Japanese Encephalitis
75%
Clinical Trial
25%
Virus Vaccine
25%
Live Vaccine
25%
Envelope Protein
25%
Recombinant DNA
25%
Dengue Virus
25%
Dengue
25%
Dengue Vaccine
25%
Inactivated Vaccine
25%
Virus Encephalitis
25%
Tick Borne Encephalitis Virus
25%
DNA Immunization
25%
Diseases
25%